'a'-Position-Mutated and G4-Mutated Hemagglutinin-Neuraminidase Proteins of Newcastle Disease Virus Impair Fusion and Hemagglutinin-Neuraminidase-Fusion Interaction by Different Mechanisms

被引:3
|
作者
Chu, Fu-lu [1 ]
Wen, Hong-ling [1 ]
Zhang, Wen-qiang [3 ]
Lin, Bin [3 ]
Zhang, Yan [3 ]
Sun, Cheng-xi [1 ]
Ren, Gui-jie [2 ]
Song, Yan-yan [1 ]
Wang, Zhiyu [1 ,4 ]
机构
[1] Shandong Univ, Sch Publ Hlth, Dept Virol, Jinan 250012, Peoples R China
[2] Shandong Univ, Inst Biochem & Mol Biol, Sch Med, Jinan 250012, Peoples R China
[3] Shandong Ctr Dis Control & Prevent, Jinan, Peoples R China
[4] Minist Educ, Key Lab Expt Teratol, Jinan, Peoples R China
基金
中国国家自然科学基金;
关键词
Paramyxovirus; Hemagglutinin-neuraminidase protein; Heptad repeat region; Glycosylation; Membrane fusion; Hemagglutinin-neuraminidase-fusion protein complexes; AMINO-ACID SUBSTITUTIONS; F-SPECIFIC DOMAIN; HEPTAD REPEAT REGIONS; LEUCINE-ZIPPER MOTIF; HN PROTEIN; PARAINFLUENZA VIRUS; MUTATIONAL ANALYSIS; MEMBRANE-FUSION; GLOBULAR DOMAIN; CELL-FUSION;
D O I
10.1159/000341613
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Objectives: To determine the effects of heptad repeat regions (HRs) and N-linked carbohydrate sites of the Newcastle disease virus hemagglutinin-neuraminidase (HN) protein on fusion of HN and fusion (F) proteins and HN- F interaction. Methods: We mutated six 'a' residues in the HRs and four asparagines in N-linked carbohydrate sites to alanine in the HN protein. A vaccinia-T7 RNA polymerase expression system was used to express HN cDNAs in BHK-21 cells to determine the HN functions. Deglycosylation was treated with PGNase F digestion. The formation of HN- F protein complexes was determined by the coimmunoprecipitation assay. Results: Each HR-mutated protein interfered with fusion and the HN- F interaction. The G4-mutated protein not only impaired fusion and HN- F interaction but also decreased activities in cell fusion promotion, hemadsorption and neuraminidase. Conclusions: It is assumed that two different mechanisms for mutations in these two regions are responsible for the decreased fusion promotion activity and the reduced ability of interaction with F protein. Mutations in the HRs impair fusion and HN-F interaction by altering the transmission of a signal from the globular domain to the F-specific region in the stalk, but the G4 mutation modulates fusion and HN-F interaction by the misfolding of some important structures. Copyright (c) 2012 S. Karger AG, Basel
引用
收藏
页码:27 / 36
页数:10
相关论文
共 10 条
  • [1] Two single mutations in the fusion protein of Newcastle disease virus confer hemagglutinin-neuraminidase independent fusion promotion and attenuate the pathogenicity in chickens
    Ji, Yanhong
    Liu, Tao
    Jia, Yane
    Liu, Bin
    Yu, Qingzhong
    Cui, Xiaole
    Guo, Fengfeng
    Chang, Huiyun
    Zhu, Qiyun
    VIROLOGY, 2017, 509 : 146 - 151
  • [2] Different Origins of Newcastle Disease Virus Hemagglutinin-Neuraminidase Protein Modulate the Replication Efficiency and Pathogenicity of the Virus
    Jin, Ji-hui
    Cheng, Jin-long
    He, Zi-rong
    Ren, Ying-chao
    Yu, Xiao-hui
    Song, Yang
    Yang, Hui-ming
    Yang, Yan-ling
    Liu, Tong
    Zhang, Guo-zhong
    FRONTIERS IN MICROBIOLOGY, 2017, 8
  • [3] Interaction between the Hemagglutinin-Neuraminidase and Fusion Glycoproteins of Human Parainfluenza Virus Type III Regulates Viral Growth In Vivo
    Xu, Rui
    Palmer, Samantha G.
    Porotto, Matteo
    Palermo, Laura M.
    Niewiesk, Stefan
    Wilson, Ian A.
    Moscona, Anne
    MBIO, 2013, 4 (05):
  • [4] The Immunogenicity of a Novel Chimeric Hemagglutinin-Neuraminidase-Fusion Antigen from Newcastle Disease Virus by Oral Delivery of Transgenic Canola Seeds to Chickens
    Motamedi, Mohammad Javad
    Ebrahimi, Mohammad Majid
    Shahsavandi, Shahla
    Amani, Jafar
    Kazemi, Rouhollah
    Jafari, Mahyat
    Salmanian, Ali-Hatef
    MOLECULAR BIOTECHNOLOGY, 2020, 62 (6-7) : 344 - 354
  • [5] Syncytia generated by hemagglutinin-neuraminidase and fusion proteins of virulent Newcastle disease virus induce complete autophagy by activating AMPK-mTORC1-ULK1 signaling >
    Ren, Shanhui
    Rehman, Zaib Ur
    Shi, Mengyu
    Yang, Bin
    Qu, Yurong
    Yang, Xiao Feng
    Shao, Qi
    Meng, Chunchun
    Yang, Zengqi
    Gao, Xiaolong
    Sun, Yingjie
    Ding, Chan
    VETERINARY MICROBIOLOGY, 2019, 230 : 283 - 290
  • [6] Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells In Vitro: Contribution of the Cleavage Site of Fusion Protein and Second Sialic Acid Binding Site of Hemagglutinin-Neuraminidase
    Rangaswamy, Udaya S.
    Wang, Weijia
    Cheng, Xing
    McTamney, Patrick
    Carroll, Danielle
    Jin, Hong
    JOURNAL OF VIROLOGY, 2017, 91 (16)
  • [7] Direct interaction of the molecular chaperone GRP78/BiP with the Newcastle disease virus hemagglutinin-neuraminidase protein plays a vital role in viral attachment to and infection of culture cells
    Han, Chenxin
    Xie, Ziwei
    Lv, Yadi
    Liu, Dingxiang
    Chen, Ruiai
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [8] C-terminal truncation of the hemagglutinin-neuraminidase (HN) protein enhances the virulence and immunogenicity of Newcastle disease virus (NDV) vaccine strain V4
    Xiangfei Ren
    Zhe Zeng
    Yu Shang
    Lun Yao
    Li Li
    Wenting Zhang
    Yunqing Guo
    Hongcai Wang
    Rongrong Zhang
    Huabin Shao
    Sishun Hu
    Qingping Luo
    Guoyuan Wen
    Archives of Virology, 2023, 168
  • [9] C-terminal truncation of the hemagglutinin-neuraminidase (HN) protein enhances the virulence and immunogenicity of Newcastle disease virus (NDV) vaccine strain V4
    Ren, Xiangfei
    Zeng, Zhe
    Shang, Yu
    Yao, Lun
    Li, Li
    Zhang, Wenting
    Guo, Yunqing
    Wang, Hongcai
    Zhang, Rongrong
    Shao, Huabin
    Hu, Sishun
    Luo, Qingping
    Wen, Guoyuan
    ARCHIVES OF VIROLOGY, 2023, 168 (08)
  • [10] A live attenuated recombinant chimeric parainfluenza virus (PIV) candidate vaccine containing the hemagglutinin-neuraminidase and fusion glycoproteins of PIV1 and the remaining proteins from PIV3 induces resistance to PIV1 even in animals immune to PIV3
    Tao, T
    Davoodi, F
    Cho, CJ
    Skiadopoulos, MH
    Durbin, AP
    Collins, PL
    Murphy, BR
    VACCINE, 2000, 18 (14) : 1359 - 1366